FDA approves chewable version of Zyrtec allergy medicine for children

FDA approves chewable version of Zyrtec allergy medicine for children

NEW YORK, N.Y., April 28, 2004 -- The FDA approved a chewable version of a popular antihistamine for allergies and chronic hives in children aged 2 years and up. Zyrtec (cetirizine HCl) chewable tablets are a new option for kids at the in-between stage -- they've outgrown the syrup formulation, but they still aren't ready to swallow a pill.
 
The grape-flavored tablets can be taken with or without food or water. Each dose is individually packaged, obviating the need to measure doses, and enabling users to carry only what they need.

Zyrtec is approved to treat indoor and outdoor allergies in children as young as two. In studies, side effects included drowsiness, headache, sore throat, and stomachache. Most were mild or moderate. Most children weren't bothered by side effects enough to stop taking Zyrtec.

Source: Pfizer Inc. and UCB Pharma

Posted: April 2004


View comments

Hide
(web3)